On Wednesday, Satsuma Pharmaceuticals Inc. [NASDAQ:STSA] has a current price of $4.22, coming out to a daily percentage change of 8.48% with a 52-week range of $3.77 – $36.10.
Other data for the company is as follows:
- Stochastic %K of 22.7
- Weighted Alpha of 4.3
Analysts have the price target for Satsuma Pharmaceuticals Inc. [STSA] at 4.75. Daily swings are between $3.89 and $4.35.
The Price is right
Holding a Market Cap of $73.05 million, Satsuma Pharmaceuticals Inc. has seen a trading range over the last year of $3.77-$36.10.
For the last five days, STSA is up from its last closing price. The average shares trading hands each day is 2.29M.
Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for STSA. When we apply the Elder Force Index to Satsuma Pharmaceuticals Inc., we are seeing an Elder Force Indicator number of 385275.0.
In the last quarter, STSA made a profit of 94000.0.
Looking at popular technical indicators, the company’s 5-day moving average is 3.97 compared to the 50-day moving average of 3.90%. So, we are clearly seeing an upward trajectory here.
The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. STSA currently holds a 9-day RSI of 20.07%, while 100-day RSI stands at 41.75%.
Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. STSA’s 9-day MACD is 0.05 and the company’s 100-day MACD stands at -17.66.
Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.
The major holders for this stock are 11.91% by insiders and 77.85% by institutions. Regarding institutional holdings, RA Capital Management, L.P. owns 26.89%, while the second top holder, Tpg Group Holdings (sbs) Advisors, Inc., currently owns 10.83%.
Over the last six months, insiders have sold 750 with the most recent transaction from O’Neil Thomas P., Chief Financial Officer, with a sell at price 22.19 per share.
Overall, the recommended rating for STSA is Moderate Buy. Currently, the company has 5 analysts watching the stock, and the average quarterly earnings estimate is -0.69.
To review, the current 1-year target estimate is sitting at 4.75, while the current price 4.22. Based on this, we expect the stock to rise considering the aforementioned fundamentals.